ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 50 filers reported holding ARCELLX INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $162,800,189 | +9.8% | 4,537,352 | -3.3% | 0.01% | +16.7% |
| Q2 2023 | $148,329,357 | -10.3% | 4,690,998 | -12.6% | 0.01% | +50.0% |
| Q1 2023 | $165,332,004 | +312.5% | 5,366,180 | +314.8% | 0.01% | +100.0% |
| Q4 2022 | $40,075,728 | +170.7% | 1,293,600 | +64.0% | 0.00% | +100.0% |
| Q3 2022 | $14,803,000 | +31.3% | 788,668 | +26.4% | 0.00% | +100.0% |
| Q2 2022 | $11,277,000 | – | 623,718 | +4797730.8% | 0.00% | – |
| Q1 2022 | $0 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $99,440,000 | 48.67% |
| AJU IB Investment Co., Ltd. | 1,380,890 | $24,966,000 | 48.34% |
| NEA Management Company, LLC | 6,750,264 | $112,703,000 | 5.79% |
| Samsara BioCapital, LLC | 1,063,835 | $19,234,000 | 5.13% |
| Novo Holdings A/S | 4,016,878 | $72,625,000 | 3.58% |
| CLOUGH CAPITAL PARTNERS L P | 1,165,533 | $20,953,000 | 2.60% |
| Soleus Capital Management, L.P. | 909,739 | $16,448,000 | 2.57% |
| CAXTON CORP | 101,719 | $1,839,000 | 2.47% |
| Cormorant Asset Management, LP | 1,525,000 | $27,572,000 | 2.08% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,470,559 | $44,668,000 | 1.70% |